BRPI9915208A - preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação. - Google Patents

preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.

Info

Publication number
BRPI9915208A
BRPI9915208A BRPI9915208A BRPI9915208A BRPI9915208A BR PI9915208 A BRPI9915208 A BR PI9915208A BR PI9915208 A BRPI9915208 A BR PI9915208A BR PI9915208 A BRPI9915208 A BR PI9915208A BR PI9915208 A BRPI9915208 A BR PI9915208A
Authority
BR
Brazil
Prior art keywords
moxifloxacin
pharmaceutical
oral application
preparation process
tablet preparations
Prior art date
Application number
BRPI9915208A
Other languages
English (en)
Inventor
Patrick Bosche
Hans Friedrich Mahler
Claus Weisemann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI9915208(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BRPI9915208A publication Critical patent/BRPI9915208A/pt
Publication of BRPI9915208B1 publication Critical patent/BRPI9915208B1/pt
Publication of BRPI9915208B8 publication Critical patent/BRPI9915208B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

patente de invenção: <b>"preparado farmacêutico de moxifloxacina"<d>. a presente invenção refere-se a um preparado farmacêutico para a aplicação oral, que contém moxifloxacina, seu sal e/ou hidrato, bem como lactose um processo para a sua preparação, em como o emprego deste preparado para o combate de infecções bacterianas no homem ou nos animais.
BRPI9915208 1998-11-10 1999-10-29 preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação. BRPI9915208B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10
PCT/EP1999/008230 WO2000027398A1 (de) 1998-11-10 1999-10-29 Pharmazeutische zubereitung von moxifloxacin

Publications (3)

Publication Number Publication Date
BRPI9915208A true BRPI9915208A (pt) 2001-07-31
BRPI9915208B1 BRPI9915208B1 (pt) 2011-11-01
BRPI9915208B8 BRPI9915208B8 (pt) 2021-07-06

Family

ID=7889824

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9915208-8A BR9915208A (pt) 1998-11-10 1999-10-29 Preparado farmacêutico de moxifloxacina
BRPI9915208 BRPI9915208B8 (pt) 1998-11-10 1999-10-29 preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9915208-8A BR9915208A (pt) 1998-11-10 1999-10-29 Preparado farmacêutico de moxifloxacina

Country Status (41)

Country Link
US (1) US6610327B1 (pt)
EP (1) EP1128831B1 (pt)
JP (1) JP4809978B2 (pt)
KR (1) KR100650489B1 (pt)
CN (1) CN1149993C (pt)
AR (1) AR021074A1 (pt)
AT (1) ATE279193T1 (pt)
AU (1) AU745282B2 (pt)
BG (1) BG64974B1 (pt)
BR (2) BR9915208A (pt)
CA (1) CA2349161C (pt)
CO (1) CO5070571A1 (pt)
CU (1) CU23260B7 (pt)
CZ (1) CZ292069B6 (pt)
DE (1) DE59910858D1 (pt)
DK (1) DK1128831T3 (pt)
EE (1) EE04418B1 (pt)
ES (1) ES2229786T3 (pt)
HK (1) HK1042245B (pt)
HN (1) HN1999000183A (pt)
HR (1) HRP20010332B1 (pt)
HU (1) HU229065B1 (pt)
ID (1) ID29089A (pt)
IL (2) IL142642A0 (pt)
MA (1) MA26757A1 (pt)
MY (1) MY121114A (pt)
NO (1) NO319342B1 (pt)
NZ (1) NZ511554A (pt)
PE (1) PE20001304A1 (pt)
PL (1) PL194020B1 (pt)
PT (1) PT1128831E (pt)
RU (1) RU2230555C9 (pt)
SI (1) SI1128831T1 (pt)
SK (1) SK283936B6 (pt)
SV (1) SV1999000194A (pt)
TR (1) TR200101310T2 (pt)
TW (1) TW580388B (pt)
UA (1) UA72483C2 (pt)
UY (1) UY25792A1 (pt)
WO (1) WO2000027398A1 (pt)
ZA (1) ZA200103141B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
WO2005020998A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
ES2391132T3 (es) * 2008-10-09 2012-11-21 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Uso de disolventes orgánicos en la granulación húmeda de moxifloxacino
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
RU2633477C2 (ru) * 2011-11-30 2017-10-12 Тояма Кемикал Ко., Лтд. Таблетка, содержащая гидрат метансульфоната 1-циклопропил-8-(дифторметокси)-7-[(1r)-1-метил-2, 3-дигидро-1н-изоиндол-5-ил]-4-оксо-1, 4-дигидрохинолин-3-карбоновой кислоты
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
RU2073673C1 (ru) * 1987-10-19 1997-02-20 Пфайзер Инк. Рацемические и оптические активные производные тетралина и 7-гидрокситетралина
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (pt) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Also Published As

Publication number Publication date
SK283936B6 (sk) 2004-05-04
AR021074A1 (es) 2002-06-12
SV1999000194A (es) 2000-10-16
PL348112A1 (en) 2002-05-06
TW580388B (en) 2004-03-21
SI1128831T1 (en) 2005-04-30
RU2230555C9 (ru) 2006-02-27
DE59910858D1 (de) 2004-11-18
UA72483C2 (en) 2005-03-15
MY121114A (en) 2005-12-30
EE04418B1 (et) 2005-02-15
CN1149993C (zh) 2004-05-19
CN1325306A (zh) 2001-12-05
PT1128831E (pt) 2005-01-31
NO20012248D0 (no) 2001-05-07
EP1128831A1 (de) 2001-09-05
AU745282B2 (en) 2002-03-21
NZ511554A (en) 2003-07-25
CZ292069B6 (cs) 2003-07-16
IL142642A0 (en) 2002-03-10
ZA200103141B (en) 2002-05-07
CZ20011652A3 (cs) 2001-08-15
NO319342B1 (no) 2005-07-18
KR100650489B1 (ko) 2006-11-28
BG64974B1 (bg) 2006-11-30
TR200101310T2 (tr) 2001-10-22
ATE279193T1 (de) 2004-10-15
MA26757A1 (fr) 2004-12-20
WO2000027398A1 (de) 2000-05-18
AU1267400A (en) 2000-05-29
HK1042245B (zh) 2005-03-11
EE200100259A (et) 2002-12-16
BRPI9915208B1 (pt) 2011-11-01
CU23260B7 (es) 2008-01-24
PL194020B1 (pl) 2007-04-30
SK6102001A3 (en) 2001-12-03
HN1999000183A (es) 1999-11-01
BRPI9915208B8 (pt) 2021-07-06
HRP20010332A2 (en) 2002-06-30
CA2349161C (en) 2008-01-29
KR20010089424A (ko) 2001-10-06
UY25792A1 (es) 2001-08-27
RU2230555C2 (ru) 2004-06-20
HUP0104762A3 (en) 2002-10-28
ID29089A (id) 2001-07-26
IL142642A (en) 2006-10-05
BR9915208A (pt) 2001-07-31
CA2349161A1 (en) 2000-05-18
PE20001304A1 (es) 2000-12-30
JP2002529415A (ja) 2002-09-10
ES2229786T3 (es) 2005-04-16
JP4809978B2 (ja) 2011-11-09
DK1128831T3 (da) 2005-01-17
HK1042245A1 (en) 2002-08-09
HU229065B1 (en) 2013-07-29
US6610327B1 (en) 2003-08-26
NO20012248L (no) 2001-06-06
BG105459A (en) 2001-12-29
HUP0104762A2 (hu) 2002-05-29
HRP20010332B1 (hr) 2011-01-31
EP1128831B1 (de) 2004-10-13
CO5070571A1 (es) 2001-08-28

Similar Documents

Publication Publication Date Title
BRPI9915208A (pt) preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR0313164A (pt) compostos com o sistema biciclo[4.2.1] nonano para o tratamento de infecções por flaviviridae
BR0015908A (pt) Emprego de compostos org nicos no tratamento de doenças
BRPI0408236A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
BR0214132A (pt) Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, método para o tratamento do organismo animal humano ou não humano para combater infecção bacteriana
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
BR0214583A (pt) Formulações compreendendo um composto de cefalosporina e seus usos no tratamento de infecções bacterianas em gatos e cães
BG103552A (bg) Терапевтични средства
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
BR9911094A (pt) Composições e métodos para o tratamento detosse
BR9714145B1 (pt) composto ou seu sal farmaceuticamente aceitável e composição farmacêutica compreendendo o mencionado composto.
BR9917047A (pt) Composto de piperazina, método para prepará-lo, composição farmacêutica contendo-o e seu uso
BR0012942A (pt) Aplicação de flupirtin para a diminuição de dores em doenças articulares degenerativas de cães e gatos
BR9809457A (pt) Sais de peptìdeo de bpc com atividade organo-protetora, o processo para sua preparação e seu uso em terapia.
PT1117409E (pt) Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
BR0011845A (pt) Complexo farmacêutico
PT786998E (pt) A utilizacao de ¬r-(z)|-alfa-(metoxiimino)-alfa-(1-azabiciclo-¬2.2.2|-oct-3-il) acetonitrilo para reduzir a formacao de beta amiloide a4 na doenca de alzheimer
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
BR0113296A (pt) Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos
BR9808305A (pt) Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor.
BR0113294A (pt) Aplicação de triazintrion-sulfóxidos para comebater coccidioses
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções